Connect with us

Hi, what are you looking for?

Bnreport Business News Report

Politics

Gilead Sciences’ remdesivir to be available for selected Covid-19 patients in the UK

Gilead Sciences Incs (NASDAQ:GILD) remdesivir will de administered to selected Covid-19 patients in ..

Gilead Sciences Incs (NASDAQ:GILD) remdesivir will de administered to selected Covid-19 patients in the UK.

The Medicines and Healthcare Products Regulatory Agency granted on Tuesday temporary access to the drug, which is not approved in any country.

READ: Gilead Sciences' remdesivir to be distributed in 127 countries[hhmc]

The government said that treatment will be prioritised for patients likely to benefit the most due to limited supplies.

Remdesivir is currently being used in the US and in Japan as an emergency treatment, while Gilead agreed licensing agreements with five generic pharmaceutical manufacturers to supply in 127 countries earlier this month.

Read More – Source
[contf]
[contfnew]

Proactiveinvestors

[contfnewc]
[contfnewc]

You May Also Like

Politics

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae.

Finance

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Tech

Enlarge/ You wouldn't really want to use Nvidia's ..

Finance

Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora.

%d bloggers like this: